Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-06 · accession 0001237899-21-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2021-08-10 | 2021-08-06 | REGN | SING GEORGE L | Dir | S - Sale | $612.42 | -350 | 3,350 | -9% | -$214.3K |
| M | 2021-08-10 | 2021-08-06+ | REGN | SING GEORGE L | Dir | S - Sale | $612.35 | -6,600 | 50.7K | -12% | -$4.04M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-06 | S | D | 350 | $612.42 | 3,350 | I | — | — | |
| 2 | Common | Common Stock | 2021-08-10 | S | D | 1,000 | $613.01 | 48,063 | D | — | — | (F1) Represents volume-weighted average price of sales of 1,000 shares of Company stock on August 10, 2021 at prices ranging from $613.00 to $613.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 10, 2021 at each separate price. |
| 3 | Common | Common Stock | 2021-08-10 | S | D | 1,000 | $614.00 | 49,063 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-10 | S | D | 600 | $615.00 | 50,063 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-06 | S | D | 3,000 | $611.43 | 51,663 | D by Trust for Son | — | — | |
| 6 | Common | Common Stock | 2021-08-06 | S | D | 1,000 | $611.23 | 50,663 | D | — | — |